0000878088-12-000016.txt : 20120109
0000878088-12-000016.hdr.sgml : 20120109
20120109182012
ACCESSION NUMBER: 0000878088-12-000016
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120105
FILED AS OF DATE: 20120109
DATE AS OF CHANGE: 20120109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Campanelli Paul
CENTRAL INDEX KEY: 0001392459
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10827
FILM NUMBER: 12518446
MAIL ADDRESS:
STREET 1: C/O PAR PHARMACEUTICAL COMPANIES, INC.
STREET 2: 300 TICE BOULEVARD
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PAR PHARMACEUTICAL COMPANIES, INC.
CENTRAL INDEX KEY: 0000878088
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223122182
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 TICE BOULEVARD
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
BUSINESS PHONE: 201-802-4000
MAIL ADDRESS:
STREET 1: 300 TICE BOULEVARD
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
FORMER COMPANY:
FORMER CONFORMED NAME: PHARMACEUTICAL RESOURCES INC
DATE OF NAME CHANGE: 19940526
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0304
4
2012-01-05
0
0000878088
PAR PHARMACEUTICAL COMPANIES, INC.
PRX
0001392459
Campanelli Paul
C/O PAR PHARMACEUTICAL COMPANIES, INC.
300 TICE BOULEVARD
WOODCLIFF LAKE
NJ
07677
0
1
0
0
Chief Operating Officer
Common Stock
2012-01-06
4
F
0
806
34.01
D
47118
D
Restricted Stock Units
2012-01-05
4
A
0
25438
0
A
2016-01-05
2016-01-05
Common Stock
25438
25438
D
Common Stock, Option to Buy
32.76
2012-01-05
4
A
0
50875
0
A
2022-01-04
Common Stock
50875
50875
D
Performance Stock Units
2012-01-05
4
A
0
25438
0
A
Common Stock
25438
25438
D
Surrender of shares in payment of tax withholding due as a result of the vesting of Restricted Stock granted in accordance with Rule 16b-3.
Includes (i) 31,543 shares of Common Stock, and (ii) 15,575 shares of Restricted Stock held by Mr. Campanelli.
Award of Restricted Stock Units (RSUs) under the Company's 2004 Performance Equity Plan, which RSUs vest on the fourth anniversary of the date of grant (1/5/2016). Each RSU will be convertible into one share of the Company's Common Stock on 1/5/2016.
Award of Option to purchase shares of Common Stock under the Company's 2004 Performance Equity Plan. 25% vest on the first anniversary of the date of grant and an additional 25% vest on each anniversary until fully vested.
Award of Performance Stock Units (PSUs) under the Company's 2004 Performance Equity Plan, which PSUs vest only upon the achievement of certain predetermined financial, operational and strategic goals over a three-year period. Each PSU will be convertible into one share of the Company's Common Stock upon vesting.
/s/ Marian E. Gustafson for Paul V. Campanelli
2012-01-09